A Bismuth Metal-Organic Framework As a Contrast Agent for X-ray Computed Tomography

Lee Robison,Lin Zhang,Riki J. Drout,Peng Li,Chad R. Haney,Anlil Brikha,Hyunho Noh,B. Layla Mehdi,Nigel D. Browning,Vinayak P. Dravid,Qun Cui,Timur Islamoglu,Omar K. Farha
DOI: https://doi.org/10.1021/acsabm.8b00778
2019-01-01
ACS Applied Bio Materials
Abstract:A new bismuth metal-organic framework (MOF), bismuth-NU-901 (Bi-NU-901), featuring the scu topology and a pore with a diameter of ∼11 Å, was solvothermally synthesized, and its use as an X-ray computed tomography (CT) contrast agent was tested. X-ray CT is a common diagnostic method used in the medical field. Inside the body, contrast media enhance the distinction between tissues and organs of similar density. Bi-NU-901 consists of eight connected Bi6 nodes and tetratopic 1,3,5,8-(p-benzoate)pyrene linkers (TBAPy). Numerous material characterization studies including powder X-ray diffraction (PXRD), scanning transmission electron microscopy (STEM), and DFT pore size distribution support the scu structure. Additionally, given the framework's high density of nontoxic heavy atoms, Bi-NU-901 was evaluated as an X-ray computed tomography (CT) agent. Importantly, in vitro studies revealed this new bismuth MOF demonstrates ∼7 times better contrast intensity compared to a zirconium MOF featuring the same topology and ∼14 times better contrast than a commercially available CT contrast agent. These results suggest bismuth MOFs may be promising CT contrast agents.
What problem does this paper attempt to address?